HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Clinical trial NCT04975698 · COMPLETED

Trial details

NCT number: NCT04975698
Sponsor: Catherine Bollard
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Associated Lymphoma

Start date: 2021-10-25
Primary completion: 2025-11-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.